Evaluation of serological assays for the diagnosis of HIV infection in adults

被引:6
作者
Bangalee, Avania [1 ,2 ]
Bhoora, Sachin [3 ]
Punchoo, Rivak [2 ,3 ]
机构
[1] Univ Pretoria, Fac Hlth Sci, Dept Med Virol, Pretoria, South Africa
[2] Natl Hlth Lab Serv, Tshwane Acad Div, Tshwane, South Africa
[3] Univ Pretoria, Fac Hlth Sci, Dept Chem Pathol, Pretoria, South Africa
关键词
human immunodeficiency virus; HIV; enzyme immunoassay; enzyme-linked immunosorbent assay; EIA; ELISA; analytical error; HIV biomarkers; HIV diagnosis; ANTIBODY; IMMUNOASSAYS; SENSITIVITY; PERFORMANCE; POINT; TESTS;
D O I
10.4102/safp.v63i1.5316
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serological tests based on the enzyme immunoassay (EIA) are the primary tool for the diagnosis of human immunodeficiency virus (HIV) in adults and have rapidly evolved to quicker, affordable and more accurate test formats to detect early HIV infection. Second-and third-generation HIV rapid tests detect the immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies to the HIV and are used at the point of care and in HIV self-testing. The tests are affordable and accessible in state and private diagnostic laboratories. The present-day fourth- and fifth-generation EIAs can detect both p24 antigen and IgG and IgM HIV antibodies and thereby diagnose early HIV infection at approximately 2 weeks. The fourth-and fifth-generation EIAs also report sensitivity and specificity of more than 99%. The correct interpretation of HIV diagnosis of false-positive and false-negative EIA test results requires collaborative scrutiny of patient factors and laboratory test methodologies.
引用
收藏
页数:5
相关论文
共 40 条
[1]   Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution [J].
Alexander, Thomas S. .
CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (04) :249-253
[2]   A novel acute HIV infection staging system based on 4th generation immunoassay [J].
Ananworanich, Jintanat ;
Fletcher, James L. K. ;
Pinyakorn, Suteeraporn ;
van Griensven, Frits ;
Vandergeeten, Claire ;
Schuetz, Alexandra ;
Pankam, Tippawan ;
Trichavaroj, Rapee ;
Akapirat, Siriwat ;
Chomchey, Nitiya ;
Phanuphak, Praphan ;
Chomont, Nicolas ;
Michael, Nelson L. ;
Kim, Jerome H. ;
de Souza, Mark .
RETROVIROLOGY, 2013, 10
[3]  
[Anonymous], 2016, NAT HIV TEST SERV PO
[4]   High level of HIV false positives using EIA-based algorithm in survey: Importance of confirmatory testing [J].
Augusto, Angelo do Rosario ;
Iriemenam, Nnaemeka C. ;
Kohatsu, Luciana ;
de Sousa, Leonardo ;
Maueia, Cremildo ;
Hara, Christine ;
Mula, Flora ;
Cuamba, Gercio ;
Chelene, Imelda ;
Langa, Zainabo ;
Lohman, Nathaniel ;
Faife, Flavio ;
Giles, Denise ;
Sabonete, Acacio Jose ;
Gudo, Eduardo Samo ;
Jani, Ilesh ;
Parekh, Bharat S. .
PLOS ONE, 2020, 15 (10)
[5]  
Barik S. K., 2018, J AIDS CLIN RES, V9, P1, DOI DOI 10.4172/2155-6113.1000762
[6]   Screening for acute HIV infection in South Africa: finding acute and chronic disease [J].
Bassett, I. V. ;
Chetty, S. ;
Giddy, J. ;
Reddy, S. ;
Bishop, K. ;
Lu, Z. ;
Losina, E. ;
Freedberg, K. A. ;
Walensky, R. P. .
HIV MEDICINE, 2011, 12 (01) :46-53
[7]   High rates of forward transmission events after acute/early HIV-1 infection [J].
Brenner, Bluma G. ;
Roger, Michel ;
Routy, Jean-Pierre ;
Moisi, Daniela ;
Ntemgwa, Michel ;
Matte, Claudine ;
Baril, Jean-Guy ;
Thomas, Rejean ;
Rouleau, Danielle ;
Bruneau, Julie ;
Leblanc, Roger ;
Legault, Mario ;
Tremblay, Cecile ;
Charest, Hugues ;
Wainberg, Mark A. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (07) :951-959
[8]  
Centers for Disease Control and Prevention (CDC), 2021, WHAT IS HIV
[9]   Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing [J].
Chappel, Roderick J. ;
Wilson, Kim M. ;
Dax, Elizabeth M. .
FUTURE MICROBIOLOGY, 2009, 4 (08) :963-982
[10]   Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay [J].
Chavez, Pollyanna ;
Wesolowski, Laura ;
Patel, Pragna ;
Delaney, Kevin ;
Owen, S. Michele .
JOURNAL OF CLINICAL VIROLOGY, 2011, 52 :S51-S55